Together, our results indicate that in mammary tumor cells GATA3 directly activates the transcription of FOS to maintain their luminal and epithelial features while concurrently repressing the transcription of FOSL1 to suppress aberrant mesenchymal differentiation, i.e., inhibiting EMT. The gene discussed is GATA3; the disease is breast cancer.